Siro™ Drug Eluting Stent
Siro™ drug eluting stent sets the bar high.
The Siro Drug Eluting Stent combines the U.S. patented Direct-Stent® design, the proven success of Sirolimus drug to reduce tissue ingrowth and proliferation, leading to reduced restenosis.
- Trusted and tested strength of a hybrid cell design
- Patented and proven Direct-Stent platform
- Clinically proven bioabsorbable polymer
- Crimped profile 0.9 – 1.2mm
- Semi-compliant balloon material
- Results driven Everolimus drug
- Rapid Exchange delivery system